Supplementary Table 1.
Patient value | Normal range | |
Duration of AS since | 9.9 ± 9.3 | |
diagnosis (years) | ||
Time since onset of | 16.6 ± 12.2 | |
symptoms (years) | ||
ESR (mm/hour) | 31.4 ± 20.3 | <15 |
Leucocytes (G/I) | 9.08 ± 1.92 | 3.8–10.5 |
Erythrocytes (T/I) | 4.88 ± 0.59 | 3.9–5.7 |
Platelets (G/I) | 344 ± 99 | 140–345 |
HAQ-S score (0–3) | 0.89 ± 0.51 | |
BASFI (0–10) | 4.67 ± 2.05 | |
BASMI (0–10) | 5.04 ± 2.20 |
AS, ankylosing spondylitis; BASFI, Bath Ankylosing Spondylitis Functional Index; BASMI, Bath Ankylosing Spondylitis Metrology Index; ESR, erythrocyte sedimentation rate; HAQ-S = Health Assessment Questionnaire; G/l, giga/liter; T/l, tara/liter.